Detection of chronic thromboembolic pulmonary hypertension (CTEPH) following pulmonary embolism
- Conditions
- Pulmonary embolism/chronic thromboembolic pulmonary hypertensionCirculatory SystemPulmonary embolism
- Registration Number
- ISRCTN61417303
- Lead Sponsor
- Swiss Society for Pulmonary Hypertension (Switzerland)
- Brief Summary
2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29563171 (added 08/05/2019)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 508
Men and women (no age limitations) with pulmonary embolism within the preceding 4 weeks, demonstrated by:
1. Pulmonary angiography, or
2. Contrast enhanced spiral computed tomography, or
3. High probability lung scintigraphy (perfusion and ventilation imaging)
1. Confirmed diagnosis of pulmonary arterial hypertension (PAH) or CTEPH before inclusion
2. Pre-existing severe chronic dyspnoea (New York Heart Association [NYHA] grade III or IV) due to other reasons than PE
3. Cancer or other life-threatening disease with a life expectancy less than 6 months
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method